Back
ESC Professional Premium Access

The relationship between changes of antithrombotic drug regimen after ischemic stroke and risks of clinical outcomes in patients with atrial fibrillation

Session: Atrial fibrillation and stroke: role of kidney disease and biomarkers
Topic: Stroke in Atrial Fibrillation
Speaker: Doctor T. Chao (Taipei, TW)
Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Tze-Fan Chao

Taipei Veterans General Hospital, Taipei (Taiwan)
4 presentations
0 follower

3 more presentations in this session

Stroke, mortality, and major bleeding among patients with atrial fibrillation and chronic kidney disease; insights from a contemporary large-scale population study

Speaker: Doctor Y. Ben Baruch Golan (Beer Sheva, IL)

Access
Abstract
Slides
Video
Thumbnail

Kidney function by creatinine and cystatin c and adverse cardiovascular outcomes in patients with atrial fibrillation

Speaker: Mr A. Schweigler (Basel, CH)

Access
Abstract
Slides
Video
Thumbnail

Neurofilament light chain (NFL) - a neuron-specific plasma biomarker for evaluating risk of ischemic cerebral events in atrial fibrillation

Speaker: Doctor J. Aulin (Uppsala, SE)

Access
Abstract
Slides
Video
Thumbnail

Access the full session

Atrial fibrillation and stroke: role of kidney disease and biomarkers

Speakers: Doctor T. Chao, Doctor Y. Ben Baruch Golan, Mr A. Schweigler, Doctor J. Aulin
Access
Video
Thumbnail

About the event

Image

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb